2
730
A. Buzas, F. Gagosz
LETTER
R.; Nolan, S. P. Angew. Chem. Int. Ed. 2006, 45, 1.
(
2) For the use of oxazolidinone as a source of protected 1,2-
amino alcohols, see: (a) Bhaket, P.; Morris, K.; Stauffer, C.
S.; Datta, A. Org. Lett. 2005, 7, 5875. (b) Ayad, T.;
Faugeroux, V.; Genisson, Y.; Andre, C.; Baltas, M.;
Gorrichon, L. J. Org. Chem. 2004, 69, 8775.
(h) Zhang, L.; Wang, S. J. Am. Chem. Soc. 2006, 128, 1442.
(i) Genin, E.; Toullec, P.; Antoniotti, S.; Brancour, C.;
Genêt, J. P.; Michelet, V. J. Am. Chem. Soc. 2006, 128,
3112. (j) Shi, X.; Gorin, D. J.; Toste, F. D. J. Am. Chem. Soc.
2005, 127, 5802. (k) Zhang, L.; Kozmin, S. A. J. Am. Chem.
Soc. 2005, 127, 6962. (l) Nieto-Oberhuber, C.; Lopez, S.;
Echavarren, A. M. J. Am. Chem. Soc. 2005, 127, 6178.
(m) Nieto-Oberhuber, C.; Lopez, S.; Munoz, M. P.;
Cardenas, D. J.; Bunel, E.; Nevado, C.; Echavarren, A. M.
Angew. Chem. Int. Ed. 2005, 44, 6146. (n) Markham, J. P.;
Staben, S. P.; Toste, F. D. J. Am. Chem. Soc. 2005, 127,
9708. (o) Antoniotti, S.; Genin, E.; Michelet, V.; Genêt, J. P.
J. Am. Chem. Soc. 2005, 127, 9976.
(
3) For biologically active molecules possessing an oxazolidine
fragment, see: (a) Puder, C.; Loya, S.; Hizi, A.; Zeeck, A. J.
Nat. Prod. 2001, 64, 42. (b) Thirkettle, J.; Alvarez, E.;
Boyd, H.; Brown, M.; Diez, E.; Hueso, J.; Elson, S.; Fuslton,
M.; Gershater, C.; Morata, M. L.; Perez, P. J. Antibiot. 2000,
5
3, 664.
(4) For natural compounds possessing an oxazolidine fragment,
see: (a) Pluotno, A.; Carmeli, S. Tetrahedron 2005, 61, 575.
b) Hsieh, T.-J.; Chang, F.-R.; Chia, Y.-C.; Chen, C.-Y.; Lin,
(
H.-C.; Chiu, H.-F.; Wu, Y.-C. J. Nat. Prod. 2001, 64, 1157.
5) Selected examples of oxazolidinones synthesis: (a) From
amino alcohols, see for instance: Tarnowski, A.; Retz, O.;
Baer, T.; Schmidt, R. Eur. J. Org. Chem. 2005, 1129.
(8) Robles-Machin, R.; Adrio, J.; Carretero, J. C. J. Org. Chem.
2006, 71, 5023.
(9) The work recently reported by Carretero and coworkers (see
ref. 8) was only dealing with the synthesis of oxazolidinones
substituted at the nitrogen and alkyne terminus.
(
(
b) From aziridines, see for instance: Miller, A. W.; Nguten,
S. T. Org. Lett. 2004, 6, 2301. (c) From epoxides, see for
instance: Mertin, R.; Murruzzu, C.; Pericas, M. A.; Riera, A.
J. Org. Chem. 2005, 70, 2325. (d) From carbamates, see for
instance: Tiecco, M.; Testaferri, L.; Temperini, A.; Terlizzi,
R.; Bagnoli, L.; Marini, F.; Santi, C. Synthesis 2005, 579.
(10) Ozaxolidinone 6a could, however, be synthesized in 94%
yield (3 h, CH Cl , r.t.) when the more electrophilic (p-
2
2
CF Ph) PAuNTf catalyst (1 mol%) was used instead of
3
3
2
PPh AuNTf
3
2.
(11) Representative Experimental Procedure – Synthesis of 3-
Benzyl-4,4-dimethyl-1,3-oxazolidin-2-one (6d).
(e) From isocyanates, see for instance: Fuentes, A.;
Martinez-Palou, R.; Jimenez-Vasquez, H. A.; Delgado, F.;
Reyes, A.; Tamariz, J. Monatsh. Chem. 2005, 136, 177.
6) (a) Buzas, A.; Gagosz, F. Org. Lett. 2006, 8, 515. (b) For a
related transformation using homopropargylic alcohol
derivatives, see: Kang, J.-E.; Shin, S. Synlett 2006, 717.
For other examples of transformations using the crystalline
and air-stable PR AuNTf catalysts, see: (c) Mezailles, N.;
To a solution of benzyl (1,1-dimethylprop-2-ynyl)carbamic
acid tert-butyl ester (5d, 136 mg, 0.5 mmol) in 1 mL of
CH Cl was added PPh AuNTf (3.7 mg, 0.005 mmol). The
reaction mixture was stirred for 5 min, then filtered through
a small pad of silica and the solvent was removed under
reduced pressure. The residue was then purified by flash
column chromatography (PE–EtOAc, 60:40) to give
(
2
2
3
2
3
2
Ricard, L.; Gagosz, F. Org. Lett. 2005, 7, 4133. (d) Buzas,
A.; Istrate, F.; Gagosz, F. Org. Lett. 2006, 8, 1957.
7) For recent reviews on gold catalysis, see: (a) Hashmi, A. S.
K. Angew. Chem. Int. Ed. 2005, 44, 6990. (b) Hoffman-
Röder, A.; Krause, N. Org. Biomol. Chem. 2005, 3, 387.
oxazolidinone 6d (108 mg, 99%, pale yellow solid); mp 69–
1
70 °C. H NMR (400 MHz, CDCl ): d = 7.39–7.27 (m, 5 H),
3
(
4.68 (d, J = 3.3 Hz, 1 H), 4.48 (s, 2 H), 4.25 (d, J = 3.3 Hz,
1
3
1 H), 1.33 (s, 6 H). C NMR (50 MHz, CDCl ): d = 160.7,
3
154.8, 137.6, 128.6, 127.8, 127.7, 84.1, 61.5, 44.0, 27.6. IR
(CCl ): 2979, 1786, 1692, 1663, 1393, 1054 cm . MS (CI +
NH ): m/z = 235 [MNH ], 218 [MH ]. HRMS (EI): m/z
3 4
–
1
(
c) Echavarren, A. M.; Nevado, C. Chem. Soc. Rev. 2004,
4
+
+
33, 431. (d) Arcadi, A.; Di Giuseppe, S. Curr. Org. Chem.
2
004, 8, 795. (e) Hashmi, A. S. K. Gold Bull. 2003, 36, 3.
calcd for C H O N: 217.1103; found: 217.1103.
13 15 2
For some recent examples of alkyne activation by Au(I)
complexes, see: (f) Sherry, B. D.; Maus, L.; Laforteza, B.
N.; Toste, F. D. J. Am. Chem. Soc. 2006, 128, 8132.
(12) These substrates substituted at the propargylic position (5i–
n) were synthesized according to the method developed by
Petrini and coworkers. See, for instance: Mecozzi, T.;
Petrini, M. J. Org. Chem. 1999, 64, 8970.
(g) Marion, N.; Diez-Gonzales, S.; de Frémont, P.; Noble, A.
Synlett 2006, No. 17, 2727–2730 © Thieme Stuttgart · New York